Fujifilm invests $928 million to expand CDMO's biologics production facility in Denmark
Investment will double the site's drug substance manufacturing capacity and will expand its capabilities to include fill/finish, and enhance its current assembly, labeling and packaging services.
Japan's Fujifilm Corporation has announced that it will invest around 100 billion yen (USD 928 million) in the Denmark site of its CDMO subsidiary, Fujifilm Diosynth Biotechnologies, which will double the facility's current drug substance manufacturing capacity.
The capital investment will also expand the site's capabilities to include fill/finish, and enhance its current assembly, labeling and packaging services.
Production lines for bulk drug substance will be expanded with the addition of a further six mammalian cell bioreactors, bringing the total to 12 x 20,000-L bioreactors by autumn 2023, making the Denmark facility one of the few major large-scale manufacturing facilities in the bio-CDMO industry.
The development will also include the addition of the site's first fill/finish production line (added by summer 2023), featuring a fully-automated, cutting-edge system capable of producing up to approximately 35 million units per annum to cater to large-scale production.
In spring 2022, a new packaging line equipped with facilities to assemble multiple types of auto-injectors, as well as automatic labeling, will be added to meet a broad range of customer needs.
"Since the acquisition of the Denmark site last year, the facility's strong manufacturing track-record, coupled with Fujifilm Diosynth Biotechnologies' technologies enabling a stable supply of high-quality biopharmaceuticals, has led to new orders not only from existing clients but also new clients, contributing to our rapid business expansion," said Takatoshi Ishikawa, executive vice president, general manager of bio-CDMO division, Fujifilm Corporation.
In August 2019, Fujifilm paid 98 billion yen (890 million USD) to acquire Biogen’s manufacturing subsidiary in Denmark.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance